NM_002736.3:c.741+618T>A

Variant names:

• chr7-107147079-T-A
• rs2395836
• NM_002736.3:c.741+618T>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_Strong BS2

The NM_002736.3(PRKAR2B):​c.741+618T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.0021 (0 hom., cov: 0)
• Consequence: PRKAR2B NM_002736.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.0920
• Publications: 6 publications found

Genes affected

PRKAR2B (HGNC:9392): (protein kinase cAMP-dependent type II regulatory subunit beta) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol. [provided by RefSeq, Jul 2008]

ACMG classification

Our verdict: Benign. The variant received -8 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.66).
• BS2: High AC in GnomAd4 at 141 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PRKAR2B	NM_002736.3	c.741+618T>A		intron_variant	Intron 6 of 10	ENST00000265717.5	NP_002727.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PRKAR2B	ENST00000265717.5	c.741+618T>A		intron_variant	Intron 6 of 10	1	NM_002736.3	ENSP00000265717.4

Frequencies

GnomAD3 genomes AF: 0.00204 AC: 140 AN: 68498 Hom.: 0 Cov.: 0

Gnomad AFR AF: 0.00110

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00479

Gnomad ASJ AF: 0.00797

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00112

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.0351

Gnomad NFE AF: 0.00266

Gnomad OTH AF: 0.00741

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.00206 AC: 141 AN: 68602 Hom.: 0 Cov.: 0 AF XY: 0.00217 AC XY: 71 AN XY: 32744

African (AFR) AF: 0.00113 AC: 39 AN: 34548

American (AMR) AF: 0.00478 AC: 25 AN: 5226

Ashkenazi Jewish (ASJ) AF: 0.00797 AC: 10 AN: 1254

East Asian (EAS) AF: 0.00 AC: 0 AN: 1842

South Asian (SAS) AF: 0.00112 AC: 1 AN: 890

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 2448

Middle Eastern (MID) AF: 0.0370 AC: 4 AN: 108

European-Non Finnish (NFE) AF: 0.00266 AC: 56 AN: 21074

Other (OTH) AF: 0.00737 AC: 6 AN: 814

Alfa AF: 0.00 Hom.: 19023

Bravo AF: 0.00105

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.66
CADD	Benign	1.7
DANN	Benign	0.89
PhyloP100		-0.092

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2395836; hg19: chr7-106787524;